NCT04278521Active, not recruiting
Mechanism of Action of Transcranial Magnetic Stimulation
Source: ClinicalTrials.gov · Last updated 12 Dec 2025
Brief summary (registry, in English)
This is an observational neuroimaging study assessing the effects of TMS on the brains of patients with unipolar depression.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 54 (actual)
- First submitted
- 18 Feb 2020
- Start date
- Nov 2011
- Primary completion date
- Jun 2026
- Lead sponsor
- Massachusetts General Hospital
- Diseases
- Depression
- NCT number
- NCT04278521
What you commit to
- Study type: Interventional
- Participants enrolled: 54
- From Nov 2011 to the primary completion date, Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Comorbid DSM-IV primary diagnoses of schizoaffective disorder, schizophrenia or dementia.
- Substance use disorder (abuse or dependence) with active use within the last 3 months
- Severe or unstable medical illness.
Other
- MRI contraindications as determined by MGH department of radiology.
Who the study is looking for
- Males and females between the ages of 18-80
- DSM-IV diagnosis of Depressive Episode
- Patients requiring TMS treatment as part of their psychiatric care
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Massachusetts General Hospital Coordinator of this site? Confirm its status | Boston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.